Cargando…
Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction
Hypertrophic cardiomyopathy is a heart muscle disease with an annual incidence between 0.24 and 0.47/100000 in childhood. Sudden cardiac death is the most common cause of death in this population. Although some medical treatment can decrease the risk of sudden cardiac death, implantable cardioverter...
Autores principales: | Dolader, Paola, Alegria, Iosune, Martínez Olorón, Patricia, Fernandez-Doblas, Joaquin, Gran, Ferran, Roses-Noguer, Ferran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515485/ https://www.ncbi.nlm.nih.gov/pubmed/36186631 http://dx.doi.org/10.3389/fped.2022.932390 |
Ejemplares similares
-
Tips for Successful Septal Myectomy in Patients with Hypertrophic Cardiomyopathy
por: Kim, Jae Hyun
Publicado: (2018) -
On-pump intracardiac echocardiography during septal myectomy for hypertrophic cardiomyopathy
por: Williams, David M., et al.
Publicado: (2020) -
Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy
por: Salgado, Benjamin C., et al.
Publicado: (2018) -
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
por: Iacovoni, Attilio, et al.
Publicado: (2012) -
Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2020)